Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralipid versus IVIG for unexplained recurrent spontaneous abortion
ChiCTR-TRC-13003484Phase 4Recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in recurrent miscarriage (RPL) comparing Intralipid group with IVIG group (2 arms). Primary endpoint: Peripheral natural killer cell percentage. Started Jul 2012; status: recruiting.
02
Drugs
Intralipid 10%immune globulin
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on ChiCTR-TRC-13003484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003484.